Search research articles
Contact Us
Filters
Showing results (171-180 of 187) with videos related to
Page
of 19
Sort By:
Histopathology
|
January 16, 2016
Phyllodes tumours of the breast: a consensus review
Benjamin Y Tan, Geza Acs, Sophia K Apple, et al.
Breast Cancer Research and Treatment
|
December 3, 2013
Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing
Milan Radovich, Susan E Clare, Rutuja Atale, et al.
Archives of Pathology & Laboratory Medicine
|
July 1, 2010
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version)
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2021
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer
Bryan P Schneider, Guanglong Jiang, Tarah J Ballinger, et al.
JAMA Oncology
|
July 10, 2020
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial
Milan Radovich, Guanglong Jiang, Bradley A Hancock, et al.
Archives of Pathology & Laboratory Medicine
|
June 8, 2010
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 21, 2010
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, et al.
JAMA
|
December 12, 2024
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial
E Shelley Hwang, Terry Hyslop, Thomas Lynch, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 2, 2016
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group
Carsten Denkert, Stephan Wienert, Audrey Poterie, et al.
Cancer Cell
|
February 14, 2018
The Integrated Genomic Landscape of Thymic Epithelial Tumors
Milan Radovich, Curtis R Pickering, Ina Felau, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 187) with videos related to
Sort By:
Page
of 19
Histopathology
|
January 16, 2016
Phyllodes tumours of the breast: a consensus review
Benjamin Y Tan, Geza Acs, Sophia K Apple, et al.
Breast Cancer Research and Treatment
|
December 3, 2013
Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing
Milan Radovich, Susan E Clare, Rutuja Atale, et al.
Archives of Pathology & Laboratory Medicine
|
July 1, 2010
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version)
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2021
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer
Bryan P Schneider, Guanglong Jiang, Tarah J Ballinger, et al.
JAMA Oncology
|
July 10, 2020
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial
Milan Radovich, Guanglong Jiang, Bradley A Hancock, et al.
Archives of Pathology & Laboratory Medicine
|
June 8, 2010
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 21, 2010
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, et al.
JAMA
|
December 12, 2024
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial
E Shelley Hwang, Terry Hyslop, Thomas Lynch, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 2, 2016
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group
Carsten Denkert, Stephan Wienert, Audrey Poterie, et al.
Cancer Cell
|
February 14, 2018
The Integrated Genomic Landscape of Thymic Epithelial Tumors
Milan Radovich, Curtis R Pickering, Ina Felau, et al.
Page
of 19